NS
Article DetailSEC EDGAR Filings
SEC EDGAR Filings
10-Q - JOHNSON & JOHNSON
Filed:
2026-04-22
AccNo:
0000200406-26-000087
Size:
11 MB
发布时间04/22 20:02 UTC
首次发现04/22 20:04 UTC
热度107.3
重要度84
情绪+0.03
站内整理正文
优先显示结构化正文；如果正文还未抽出，则回退到摘要。
sec_edgar_index_v1 · 681 字符
Form 10-Q - Quarterly report [Sections 13 or 15(d)]: SEC Accession No. 0000200406-26-000087
Filing Date: 2026-04-22
Accepted: 2026-04-22 16:02:41
Documents: 85
Period of Report: 2026-03-29
JOHNSON & JOHNSON (Filer) CIK : 0000200406 (see all company filings) EIN. : 221024240 | State of Incorp.: NJ | Fiscal Year End: 0103 Type: 10-Q | Act: 34 | File No.: 001-03215 | Film No.: 26883662 SIC : 2834 Pharmaceutical Preparations (CF Office: 03 Life Sciences)
1 | 10-Q | jnj-20260329.htm iXBRL | 10-Q
2 | EX-31.1 CEO | a20261qex311ceocertificati.htm | EX-31.1
3 | EX-31.2 CFO | a20261qex312cfocertificati.htm | EX-31.2
4 | EX-32.1 CEO | a20261qex321ceocertificati.htm | EX-32.1